quinazolines has been researched along with organophosphonates in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 13 (59.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diasio, RB; Stagg, MP | 1 |
| Ahn, K; Fahnoe, DC; Johnson, GD; Knapp, J | 1 |
| Gallant, JE | 1 |
| Freitag, M; Herget, T; Kupfer, R; Marschall, M; Morbitzer, M; Stamminger, T | 1 |
| Goto, K | 1 |
| Holý, A; Kmonícková, E; Potmesil, P; Zídek, Z | 1 |
| Holý, A; Kmonícková, E; Krecmerová, M; Potmesil, P; Zídek, Z | 1 |
| Gibson, LM; Lebioda, L; Lovelace, LL | 1 |
| Chang, JW; Hsieh, JJ; Hsu, T; Li, YY; Shen, YC; Wang, CH; Yeh, KY | 1 |
| Bai, S; Bhadury, PS; Fan, H; Hu, D; Lu, P; Song, B; Yang, S; Zhang, X; Zhang, Y | 1 |
| Cho, EB; Hwang, JI; Kim, DK; Kim, HY; Moon, MJ; Park, S; Seong, JY | 1 |
| He, M; Hu, D; Jin, L; Luo, H; Song, B; Wu, J; Yang, S | 1 |
| Lu, Y; Qiu, G; Wu, J | 1 |
| Barrett, MO; Brown, KA; Harden, TK; Karalic, I; Risseeuw, MD; Song, L; Van Calenbergh, S | 1 |
| Peggs, KS; Sellar, RS | 1 |
| Griffiths, P; Lumley, S | 1 |
| Boeckh, M; Murphy, WJ; Peggs, KS | 1 |
| Bekerman, E; Einav, S | 1 |
| Gerna, G; Lilleri, D | 1 |
| Frange, P; Leruez-Ville, M | 1 |
| Abdel-Aal, MF; Atlam, FM; Awad, MK; Hekal, HA | 1 |
| Bar-On, S; Haynes, RK; Lantsberg, D; Laskov, I; Oiknine-Djian, E; Panet, A; Wolf, DG | 1 |
7 review(s) available for quinazolines and organophosphonates
| Article | Year |
|---|---|
Novel chemotherapeutic agents in early clinical development.
Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate | 1990 |
[Prospects for endothelin-related drugs].
Topics: Animals; Aspartic Acid Endopeptidases; Bosentan; Cardiovascular Diseases; Drug Design; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Hemodynamics; Humans; Metalloendopeptidases; Organophosphonates; Peptides, Cyclic; Quinazolines; Receptors, Endothelin; Sulfonamides; Sulfonylurea Compounds; Tetracyclines; Tetrazoles | 2004 |
Therapeutic strategies for cytomegalovirus infection in haematopoietic transplant recipients: a focused update.
Topics: Acetates; Antiviral Agents; Benzimidazoles; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Organophosphonates; Quinazolines; Ribonucleosides; T-Lymphocytes; Transplant Recipients; Transplantation, Homologous | 2014 |
Cytomegalovirus.
Topics: Acetates; Antiviral Agents; Benzimidazoles; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Transmission, Infectious; Double-Blind Method; Female; Ganciclovir; Humans; Male; Organ Transplantation; Organophosphonates; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Quinazolines; Randomized Controlled Trials as Topic; Ribonucleosides | 2014 |
Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies.
Topics: Acetates; Adoptive Transfer; Animals; Antiviral Agents; Benzimidazoles; Cell- and Tissue-Based Therapy; Clinical Trials, Phase III as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Hematopoietic Stem Cell Transplantation; Humans; Isoxazoles; Killer Cells, Natural; Leflunomide; Mice; Organophosphonates; Quinazolines; Ribonucleosides; T-Lymphocytes | 2015 |
Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.
Topics: Acetates; Adult; Animals; Antiviral Agents; Asymptomatic Diseases; Benzimidazoles; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Management; Gastroenteritis; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Monitoring, Immunologic; Organophosphonates; Pneumonia; Postoperative Complications; Quinazolines; Ribonucleosides | 2016 |
Maribavir, brincidofovir and letermovir: Efficacy and safety of new antiviral drugs for treating cytomegalovirus infections.
Topics: Acetates; Antiviral Agents; Benzimidazoles; Cytomegalovirus Infections; Cytosine; Ganciclovir; Humans; Organophosphonates; Quinazolines; Ribonucleosides | 2018 |
1 trial(s) available for quinazolines and organophosphonates
| Article | Year |
|---|---|
Novel chemotherapeutic agents in early clinical development.
Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate | 1990 |
15 other study(ies) available for quinazolines and organophosphonates
| Article | Year |
|---|---|
Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pH.
Topics: Aspartic Acid Endopeptidases; Bradykinin; Endothelin-Converting Enzymes; Humans; Hydrogen-Ion Concentration; Metalloendopeptidases; Organophosphonates; Protease Inhibitors; Quinazolines; Substance P; Substrate Specificity; Tetrazoles | 2000 |
New antiretroviral agents.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Carbamates; Deoxycytidine; Dioxolanes; Drugs, Investigational; Emtricitabine; Furans; Guanosine; HIV Fusion Inhibitors; Humans; Imidazoles; Oligopeptides; Organophosphates; Organophosphonates; Organophosphorus Compounds; Prodrugs; Protease Inhibitors; Pyridines; Pyrones; Quinazolines; Reverse Transcriptase Inhibitors; Sulfonamides; Sulfur Compounds; Tenofovir | 2001 |
Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.
Topics: Antiviral Agents; Blotting, Western; Cell Line; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Viral; Enzyme Inhibitors; Ganciclovir; Humans; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Plasmids; Quinazolines; Viral Plaque Assay; Virus Replication | 2004 |
Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine.
Topics: 2-Aminopurine; Adenine; Adjuvants, Immunologic; Animals; Anti-HIV Agents; Caffeine; Cell Survival; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Dihydropyridines; Dose-Response Relationship, Drug; Female; Flavins; Humans; Interleukin-10; Lipopolysaccharides; Macrophage Inflammatory Proteins; Macrophages; Mice; Mice, Inbred C57BL; Molecular Structure; Organophosphonates; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Theophylline; Triazoles; Tumor Necrosis Factor-alpha | 2006 |
Nucleotide analogues with immunobiological properties: 9-[2-Hydroxy-3-(phosphonomethoxy)propyl]-adenine (HPMPA), -2,6-diaminopurine (HPMPDAP), and their N6-substituted derivatives.
Topics: Adenine; Animals; Caffeine; Cell Survival; Cytokines; Dihydropyridines; Dose-Response Relationship, Drug; Female; Gene Expression; Interferon-gamma; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Nucleotides; Organophosphonates; Organophosphorus Compounds; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triazoles | 2006 |
Cooperative inhibition of human thymidylate synthase by mixtures of active site binding and allosteric inhibitors.
Topics: Allosteric Regulation; Animals; Binding Sites; Fluorescence; Humans; Kinetics; Mice; Models, Molecular; Organophosphonates; Phosphates; Pregnadienes; Protein Conformation; Quinazolines; Thymidylate Synthase | 2007 |
Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells.
Topics: Animals; Apoptosis; Blotting, Western; Bone Density Conservation Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Survival; Diphosphonates; Drug Therapy, Combination; ErbB Receptors; Female; Gefitinib; Humans; Imidazoles; Lung Neoplasms; Mice; Mice, Nude; Organophosphonates; Quinazolines; Transplantation, Heterologous; Zoledronic Acid | 2009 |
Enantioseparation and plant virucidal bioactivity of new quinazoline derivatives with alpha-aminophosphonate moiety.
Topics: 2-Propanol; Amylose; Antiviral Agents; Carbamates; Chromatography, High Pressure Liquid; Hexanes; Organophosphonates; Quinazolines; Reproducibility of Results; Stereoisomerism; Temperature; Thermodynamics; Tobacco Mosaic Virus | 2010 |
Insulin contributes to fine-tuning of the pancreatic beta-cell response to glucagon-like peptide-1.
Topics: Animals; Cell Line; ErbB Receptors; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin-Secreting Cells; Isoquinolines; Naphthalenes; Oncogene Protein v-akt; Organophosphonates; Phosphorylation; Quinazolines; Rats; Receptor Cross-Talk; Receptors, AMPA; Tetrazoles; Tyrphostins | 2011 |
Rapid synthesis and antiviral activity of (quinazolin-4-ylamino)methyl-phosphonates through microwave irradiation.
Topics: Antiviral Agents; Biological Assay; Chemistry, Pharmaceutical; Drug Design; Microwaves; Organophosphonates; Quinazolines; Solvents; Temperature; Tobacco Mosaic Virus | 2012 |
A concise synthesis of 4-imino-3,4-dihydroquinazolin-2-ylphosphonates via a palladium-catalyzed reaction of carbodiimide, isocyanide, and phosphite.
Topics: Carbodiimides; Catalysis; Cyanides; Organophosphonates; Palladium; Phosphites; Quinazolines | 2013 |
Synthesis of extended uridine phosphonates derived from an allosteric P2Y2 receptor ligand.
Topics: Allosteric Regulation; Astrocytes; Cell Line, Tumor; Humans; Ligands; Organophosphonates; Purinergic P2Y Receptor Agonists; Quinazolines; Receptors, Purinergic P2Y2; Uridine | 2014 |
Infectious disease. Combating emerging viral threats.
Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses | 2015 |
Molecular docking, molecular modeling, vibrational and biological studies of some new heterocyclic α-aminophosphonates.
Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Cell Survival; Fungi; Humans; MCF-7 Cells; Molecular Docking Simulation; Organophosphonates; Quinazolines; Spectroscopy, Fourier Transform Infrared | 2019 |
Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus.
Topics: Acetates; Antiviral Agents; Artemisinins; Benzimidazoles; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Interactions; Drug Synergism; Drugs, Investigational; Female; Ganciclovir; Humans; Organ Culture Techniques; Organophosphonates; Placenta; Pregnancy; Quinazolines; Ribonucleosides | 2019 |